Citryll Completes First Closing of a € 15M Series A to Develop its NETosis Inhibiting Antibody

Life Science

China SXT Pharmaceuticals, Inc. Announces TCM Homologous Supplements Production

Life Science

Ocumension Signs $13.5 Million Deal for China Rights to Nicox Anti-Inflammatory Eye Drug

Life Science

China News Weekly 117 – Tesla to Open Shanghai Gigafactory by Year End, City Official Says

Cannabis, Mining, Technology

Jibeier Pharm Files for IPO on Shanghai’s New Tech Innovation Board

Life Science

Lepu Bio Raises $131 Million in Series A Funding for Immunotherapies

Life Science

Zai Lab Announces $77.5 Million Collaboration for Incyte’s PD-1 mAb

Life Science

Asieris Enters $73 Million Agreement for Global Rights to Cervical Lesion Treatment

Life Science

Yuhan Out-Licenses NASH Treatment to Boehringer in $870 Million Deal

Life Science

Chi-Med’s Parent, C.K. Hutchison, Sells $288 Million of Chi-Med Stock

Life Science

Oncimmune and Biodesix Form Strategic Partnership to Unlock Full Potential of EarlyCDT® Lung in US

Life Science

Chi-Med Announces Secondary Offering of American Depositary Shares

Life Science

Pfizer’s Avastin biosimilar wins FDA approval

Life Science

CMS In-Licenses Dry Eye, Psoriasis Treatments from India’s Sun Pharma

Life Science

PeptiDream Announces New Peptide Drug Conjugate (“PDC”) Collaboration Agreement with Novartis

Life Science